{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T17:25:01Z","timestamp":1794072301475,"version":"4.8.0"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20GM125504-01"],"award-info":[{"award-number":["P20GM125504-01"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK135603"],"award-info":[{"award-number":["R01DK135603"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["P30ES030283"],"award-info":[{"award-number":["P30ES030283"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011541","name":"U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["CA191683"],"award-info":[{"award-number":["CA191683"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R21AA030638"],"award-info":[{"award-number":["R21AA030638"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The aryl hydrocarbon receptor (AHR) plays a central role in orchestrating gut barrier and mucosal immune functions in the pathogenesis of inflammatory bowel disease (IBD). Nevertheless, activation of the AHR by diverse ligands yields varied outcomes, and the downstream pathways responsible for these effects remain unknown. Here, we report that selective activation of AHR in mouse intestinal epithelial cells (IEC) by the microbial metabolite, urolithin A (UroA), triggers the Nod-like receptor pyrin domain-containing protein 6 (NLRP6) inflammasome, resulting in the release of interleukin (IL)\u221218 but not IL-1\u03b2. Further, we show that UroA-induced IL-18 in IECs is critical for IL-22, mucin 2 and REG3\u03b3 production, as well as protection against colitis. Moreover, UroA significantly upregulates IL-18 and IL-22 levels in IECs and type-3 innate lymphoid cells, respectively, in intestinal biopsies from patients with IBD patients. These results demonstrate that activation of AHR by UroA modulates intestinal barrier function through an NLRP6-IL-18-IL-22 pathway in both healthy and IBD conditions.<\/jats:p>","DOI":"10.1038\/s41467-026-73760-3","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T09:21:56Z","timestamp":1782206516000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Urolithin A activates aryl hydrocarbon receptor-NLRP6-mediated pathways in intestinal epithelial cells to modulate mucosal immunity and strengthen gut barrier integrity"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0613-8687","authenticated-orcid":false,"given":"Sweta","family":"Ghosh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8823-3670","authenticated-orcid":false,"given":"Zachary M.","family":"Vanwinkle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6736-3573","authenticated-orcid":false,"given":"Sobha Rani","family":"Bodduluri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9362-9937","authenticated-orcid":false,"given":"Subir Kumar","family":"Juin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4790-4202","authenticated-orcid":false,"given":"Mahendar","family":"Kadari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6160-4022","authenticated-orcid":false,"given":"Ankita","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9787-4537","authenticated-orcid":false,"given":"Gerald W.","family":"Dryden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1505-5429","authenticated-orcid":false,"given":"Matthew B.","family":"Lawrenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6395-6443","authenticated-orcid":false,"given":"Thirumala-Devi","family":"Kanneganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8377-353X","authenticated-orcid":false,"given":"Shesh N.","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0264-5721","authenticated-orcid":false,"given":"Misty","family":"Good","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3628-452X","authenticated-orcid":false,"given":"Pawan","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8261-3294","authenticated-orcid":false,"given":"Bodduluri","family":"Haribabu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4206-7305","authenticated-orcid":false,"given":"Venkatakrishna Rao","family":"Jala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"73760_CR1","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature10208","volume":"474","author":"KJ Maloy","year":"2011","unstructured":"Maloy, K. J. & Powrie, F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 474, 298\u2013306 (2011).","journal-title":"Nature"},{"key":"73760_CR2","doi-asserted-by":"publisher","first-page":"628157","DOI":"10.1155\/2015\/628157","volume":"2015","author":"A Michielan","year":"2015","unstructured":"Michielan, A. & D\u2019Inc\u00e0, R. Intestinal permeability in inflammatory bowel disease: pathogenesis, clinical evaluation, and therapy of leaky gut. Mediators Inflamm. 2015, 628157 (2015).","journal-title":"Mediators Inflamm."},{"key":"73760_CR3","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/QCO.0b013e32832a8a5d","volume":"22","author":"CD Packey","year":"2009","unstructured":"Packey, C. D. & Sartor, R. B. Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases. Curr. Opin. Infect. Dis. 22, 292\u2013301 (2009).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"73760_CR4","doi-asserted-by":"publisher","first-page":"645168","DOI":"10.3389\/fimmu.2021.645168","volume":"12","author":"A De Juan","year":"2021","unstructured":"De Juan, A. & Segura, E. Modulation of immune responses by nutritional ligands of aryl hydrocarbon receptor. Front Immunol. 12, 645168 (2021).","journal-title":"Front Immunol."},{"key":"73760_CR5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1146\/annurev-pharmtox-052220-115707","volume":"62","author":"L Larigot","year":"2022","unstructured":"Larigot, L. et al. Aryl hydrocarbon receptor and its diverse ligands and functions: an exposome receptor. Annu. Rev. Pharmacol. Toxicol. 62, 383\u2013404 (2022).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"73760_CR6","doi-asserted-by":"publisher","first-page":"198","DOI":"10.2174\/138920011795016818","volume":"12","author":"L Stejskalova","year":"2011","unstructured":"Stejskalova, L., Dvorak, Z. & Pavek, P. Endogenous and exogenous ligands of aryl hydrocarbon receptor: current state of art. Curr. Drug Metab. 12, 198\u2013212 (2011).","journal-title":"Curr. Drug Metab."},{"key":"73760_CR7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1053\/j.gastro.2011.04.007","volume":"141","author":"I Monteleone","year":"2011","unstructured":"Monteleone, I. et al. Aryl hydrocarbon receptor-induced signals up-regulate il-22 production and inhibit inflammation in the gastrointestinal tract. Gastroenterology 141, 237\u2013248.e231 (2011).","journal-title":"Gastroenterology"},{"key":"73760_CR8","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1053\/j.gastro.2017.08.028","volume":"153","author":"S Nikolaus","year":"2017","unstructured":"Nikolaus, S. et al. Increased tryptophan metabolism is associated with activity of inflammatory bowel diseases. Gastroenterology 153, 1504\u20131516.e1502 (2017).","journal-title":"Gastroenterology"},{"key":"73760_CR9","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.jcmgh.2021.02.007","volume":"11","author":"S Ghosh","year":"2021","unstructured":"Ghosh, S., Whitley, C. S., Haribabu, B. & Jala, V. R. Regulation of intestinal barrier function by microbial metabolites. Cell Mol Gastroenterol. Hepatol. 11, 1463\u20131482 (2021).","journal-title":"Cell Mol Gastroenterol. Hepatol."},{"key":"73760_CR10","doi-asserted-by":"publisher","first-page":"19376","DOI":"10.1073\/pnas.2000047117","volume":"117","author":"SA Scott","year":"2020","unstructured":"Scott, S. A., Fu, J. & Chang, P. V. Microbial tryptophan metabolites regulate gut barrier function via the aryl hydrocarbon receptor. Proc. Natl. Acad. Sci. USA 117, 19376\u201319387 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"73760_CR11","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/s41575-018-0054-1","volume":"15","author":"SM Man","year":"2018","unstructured":"Man, S. M. Inflammasomes in the gastrointestinal tract: infection, cancer and gut microbiota homeostasis. Nat. Rev. Gastroenterol. Hepatol. 15, 721\u2013737 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"73760_CR12","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.immuni.2007.10.002","volume":"27","author":"TD Kanneganti","year":"2007","unstructured":"Kanneganti, T. D., Lamkanfi, M. & N\u00fa\u00f1ez, G. Intracellular NOD-like receptors in host defense and disease. Immunity 27, 549\u2013559 (2007).","journal-title":"Immunity"},{"key":"73760_CR13","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2016.58","volume":"16","author":"P Broz","year":"2016","unstructured":"Broz, P. & Dixit, V. M. Inflammasomes: mechanism of assembly, regulation and signalling. Nat. Rev. Immunol. 16, 407\u2013420 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"73760_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109043","volume":"35","author":"K Venuprasad","year":"2021","unstructured":"Venuprasad, K. & Theiss, A. L. NLRP6 in host defense and intestinal inflammation. Cell Rep. 35, 109043 (2021).","journal-title":"Cell Rep."},{"key":"73760_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12555","volume":"52","author":"J Yin","year":"2019","unstructured":"Yin, J. et al. The protective roles of NLRP6 in intestinal epithelial cells. Cell Prolif. 52, e12555 (2019).","journal-title":"Cell Prolif."},{"key":"73760_CR16","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.it.2017.01.001","volume":"38","author":"M Levy","year":"2017","unstructured":"Levy, M., Shapiro, H., Thaiss, C. A. & Elinav, E. NLRP6: a multifaceted innate immune sensor. Trends Immunol. 38, 248\u2013260 (2017).","journal-title":"Trends Immunol."},{"key":"73760_CR17","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/j.cell.2015.10.048","volume":"163","author":"M Levy","year":"2015","unstructured":"Levy, M. et al. Microbiota-modulated metabolites shape the intestinal microenvironment by regulating NLRP6 inflammasome signaling. Cell 163, 1428\u20131443 (2015).","journal-title":"Cell"},{"key":"73760_CR18","doi-asserted-by":"publisher","first-page":"9601","DOI":"10.1073\/pnas.1100981108","volume":"108","author":"S Normand","year":"2011","unstructured":"Normand, S. et al. Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury. Proc. Natl. Acad. Sci. USA 108, 9601\u20139606 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"73760_CR19","doi-asserted-by":"publisher","first-page":"7187","DOI":"10.4049\/jimmunol.1100412","volume":"186","author":"GY Chen","year":"2011","unstructured":"Chen, G. Y., Liu, M., Wang, F., Bertin, J. & N\u00fa\u00f1ez, G. A functional role for Nlrp6 in intestinal inflammation and tumorigenesis. J. Immunol. 186, 7187\u20137194 (2011).","journal-title":"J. Immunol."},{"key":"73760_CR20","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/mi.2016.55","volume":"10","author":"SS Seregin","year":"2017","unstructured":"Seregin, S. S. et al. NLRP6 function in inflammatory monocytes reduces susceptibility to chemically induced intestinal injury. Mucosal Immunol. 10, 434\u2013445 (2017).","journal-title":"Mucosal Immunol."},{"key":"73760_CR21","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.celrep.2017.03.080","volume":"19","author":"SS Seregin","year":"2017","unstructured":"Seregin, S. S. et al. NLRP6 protects Il10(\u2212\/\u2212) mice from colitis by limiting colonization of Akkermansia muciniphila. Cell Rep. 19, 733\u2013745 (2017).","journal-title":"Cell Rep."},{"key":"73760_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07859-7","volume":"10","author":"R Singh","year":"2019","unstructured":"Singh, R. et al. Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway. Nat. Commun. 10, 89 (2019).","journal-title":"Nat. Commun."},{"key":"73760_CR23","first-page":"868","volume":"41","author":"Q Wang","year":"2018","unstructured":"Wang, Q. et al. Aryl hydrocarbon receptor inhibits inflammation in DSS\u2011induced colitis via the MK2\/p\u2011MK2\/TTP pathway. Int J. Mol. Med 41, 868\u2013876 (2018).","journal-title":"Int J. Mol. Med"},{"key":"73760_CR24","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.micinf.2013.06.009","volume":"15","author":"PK Anand","year":"2013","unstructured":"Anand, P. K. & Kanneganti, T. D. NLRP6 in infection and inflammation. Microbes Infect. 15, 661\u2013668 (2013).","journal-title":"Microbes Infect."},{"key":"73760_CR25","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.cell.2011.04.022","volume":"145","author":"E Elinav","year":"2011","unstructured":"Elinav, E. et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145, 745\u2013757 (2011).","journal-title":"Cell"},{"key":"73760_CR26","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/eji.201344135","volume":"44","author":"GY Chen","year":"2014","unstructured":"Chen, G. Y. Role of Nlrp6 and Nlrp12 in the maintenance of intestinal homeostasis. Eur. J. Immunol. 44, 321\u2013327 (2014).","journal-title":"Eur. J. Immunol."},{"key":"73760_CR27","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.cell.2015.10.072","volume":"163","author":"R Nowarski","year":"2015","unstructured":"Nowarski, R. et al. Epithelial IL\u221218 Equilibrium Controls Barrier Function in Colitis. Cell 163, 1444\u20131456 (2015).","journal-title":"Cell"},{"key":"73760_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1004603","volume":"13","author":"S Ghosh","year":"2022","unstructured":"Ghosh, S., Moorthy, B., Haribabu, B. & Jala, V. R. Cytochrome P450 1A1 is essential for the microbial metabolite, Urolithin A-mediated protection against colitis. Front. Immunol. 13, 1004603 (2022).","journal-title":"Front. Immunol."},{"key":"73760_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02990-8","volume":"22","author":"S Ghosh","year":"2024","unstructured":"Ghosh, S. et al. Inflammation-targeted delivery of Urolithin A mitigates chemical- and immune checkpoint inhibitor-induced colitis. J. Nanobiotechnol. 22, 701 (2024).","journal-title":"J. Nanobiotechnol."},{"key":"73760_CR30","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.fct.2017.07.050","volume":"108","author":"J Heilman","year":"2017","unstructured":"Heilman, J., Andreux, P., Tran, N., Rinsch, C. & Blanco-Bose, W. Safety assessment of Urolithin A, a metabolite produced by the human gut microbiota upon dietary intake of plant-derived ellagitannins and ellagic acid. Food Chem. Toxicol. 108, 289\u2013297 (2017).","journal-title":"Food Chem. Toxicol."},{"key":"73760_CR31","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s42255-019-0073-4","volume":"1","author":"PA Andreux","year":"2019","unstructured":"Andreux, P. A. et al. The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. Nat. Metab. 1, 595\u2013603 (2019).","journal-title":"Nat. Metab."},{"key":"73760_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1706111","volume":"16","author":"S Ghosh","year":"2025","unstructured":"Ghosh, S. et al. Urolithin A regulates gut: liver axis to ameliorate alcohol-associated liver disease. Front Pharm. 16, 1706111 (2025).","journal-title":"Front Pharm."},{"key":"73760_CR33","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20192195","volume":"217","author":"M Keir","year":"2020","unstructured":"Keir, M., Yi, Y., Lu, T. & Ghilardi, N. The role of IL-22 in intestinal health and disease. J. Exp. Med 217, e20192195 (2020).","journal-title":"J. Exp. Med"},{"key":"73760_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1540-2","volume":"10","author":"B Zeng","year":"2019","unstructured":"Zeng, B. et al. ILC3 functions as a double-edged sword in inflammatory bowel diseases. Cell Death Dis. 10, 315 (2019).","journal-title":"Cell Death Dis."},{"key":"73760_CR35","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1177\/1753425918785016","volume":"24","author":"J Wang","year":"2018","unstructured":"Wang, J. et al. Aryl hydrocarbon receptor\/IL-22\/Stat3 signaling pathway is involved in the modulation of intestinal mucosa antimicrobial molecules by commensal microbiota in mice. Innate Immun. 24, 297\u2013306 (2018).","journal-title":"Innate Immun."},{"key":"73760_CR36","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.immuni.2011.11.011","volume":"36","author":"J Qiu","year":"2012","unstructured":"Qiu, J. et al. The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity 36, 92\u2013104 (2012).","journal-title":"Immunity"},{"key":"73760_CR37","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/nrmicro3315","volume":"12","author":"JW Collins","year":"2014","unstructured":"Collins, J. W. et al. Citrobacter rodentium: infection, inflammation and the microbiota. Nat. Rev. Microbiol. 12, 612\u2013623 (2014).","journal-title":"Nat. Rev. Microbiol."},{"key":"73760_CR38","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jim.2015.02.003","volume":"421","author":"EP Koroleva","year":"2015","unstructured":"Koroleva, E. P. et al. Citrobacter rodentium-induced colitis: a robust model to study mucosal immune responses in the gut. J. Immunol. Methods 421, 61\u201372 (2015).","journal-title":"J. Immunol. Methods"},{"key":"73760_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2021.100519","volume":"2","author":"R Schreurs","year":"2021","unstructured":"Schreurs, R., Baumdick, M. E., Drewniak, A. & Bunders, M. J. In vitro co-culture of human intestinal organoids and lamina propria-derived CD4(+) T cells. STAR Protoc. 2, 100519 (2021).","journal-title":"STAR Protoc."},{"key":"73760_CR40","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s00535-016-1170-8","volume":"51","author":"K Nozaki","year":"2016","unstructured":"Nozaki, K. et al. Co-culture with intestinal epithelial organoids allows efficient expansion and motility analysis of intraepithelial lymphocytes. J. Gastroenterol. 51, 206\u2013213 (2016).","journal-title":"J. Gastroenterol."},{"key":"73760_CR41","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3389\/fcell.2015.00085","volume":"3","author":"OB Parks","year":"2016","unstructured":"Parks, O. B., Pociask, D. A., Hodzic, Z., Kolls, Z. K. & Good, M. Interleukin-22 signaling in the regulation of intestinal health and disease. Front. Cell Dev. Biol. 3, 85 (2016).","journal-title":"Front. Cell Dev. Biol."},{"key":"73760_CR42","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.immuni.2018.05.013","volume":"48","author":"M Colonna","year":"2018","unstructured":"Colonna, M. Innate Lymphoid cells: diversity, plasticity, and unique functions in immunity. Immunity 48, 1104\u20131117 (2018).","journal-title":"Immunity"},{"key":"73760_CR43","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1136\/gut.50.6.812","volume":"50","author":"PV Sivakumar","year":"2002","unstructured":"Sivakumar, P. V. et al. Interleukin 18 is a primary mediator of the inflammation associated with dextran sulfate sodium-induced colitis: blocking interleukin 18 attenuates intestinal damage. Gut 50, 812\u2013820 (2002).","journal-title":"Gut"},{"key":"73760_CR44","first-page":"85","volume":"3","author":"OB Parks","year":"2015","unstructured":"Parks, O. B., Pociask, D. A., Hodzic, Z., Kolls, J. K. & Good, M. Interleukin-22 signaling in the regulation of intestinal health and disease. Front Cell Dev. Biol. 3, 85 (2015).","journal-title":"Front Cell Dev. Biol."},{"key":"73760_CR45","doi-asserted-by":"publisher","first-page":"12768","DOI":"10.1073\/pnas.1300318110","volume":"110","author":"CL Zindl","year":"2013","unstructured":"Zindl, C. L. et al. IL-22-producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis. Proc. Natl. Acad. Sci. USA 110, 12768\u201312773 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"73760_CR46","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nrd4176","volume":"13","author":"R Sabat","year":"2014","unstructured":"Sabat, R., Ouyang, W. & Wolk, K. Therapeutic opportunities of the IL-22-IL-22R1 system. Nat. Rev. Drug Discov. 13, 21\u201338 (2014).","journal-title":"Nat. Rev. Drug Discov."},{"key":"73760_CR47","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/mi.2014.71","volume":"8","author":"DS Allan","year":"2015","unstructured":"Allan, D. S. et al. An in vitro model of innate lymphoid cell function and differentiation. Mucosal Immunol. 8, 340\u2013351 (2015).","journal-title":"Mucosal Immunol."},{"key":"73760_CR48","doi-asserted-by":"publisher","first-page":"919973","DOI":"10.3389\/fimmu.2022.919973","volume":"13","author":"SA Ihim","year":"2022","unstructured":"Ihim, S. A. et al. Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: Biological role in induction, regulation, and treatment. Front Immunol. 13, 919973 (2022).","journal-title":"Front Immunol."},{"key":"73760_CR49","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.cell.2014.04.007","volume":"157","author":"M Lamkanfi","year":"2014","unstructured":"Lamkanfi, M. & Dixit, V. M. Mechanisms and functions of inflammasomes. Cell 157, 1013\u20131022 (2014).","journal-title":"Cell"},{"key":"73760_CR50","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson, K. V., Deng, M. & Ting, J. P. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat. Rev. Immunol. 19, 477\u2013489 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"73760_CR51","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.4049\/jimmunol.1201065","volume":"189","author":"M Kovarova","year":"2012","unstructured":"Kovarova, M. et al. NLRP1-dependent pyroptosis leads to acute lung injury and morbidity in mice. J. Immunol. 189, 2006\u20132016 (2012).","journal-title":"J. Immunol."},{"key":"73760_CR52","doi-asserted-by":"publisher","first-page":"649","DOI":"10.3390\/ijms20030649","volume":"20","author":"K Yasuda","year":"2019","unstructured":"Yasuda, K., Nakanishi, K. & Tsutsui, H. Interleukin-18 in health and disease. Int J. Mol. Sci. 20, 649 (2019).","journal-title":"Int J. Mol. Sci."},{"key":"73760_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28478-3","volume":"13","author":"H-Y Chiang","year":"2022","unstructured":"Chiang, H.-Y. et al. IL-22 initiates an IL-18-dependent epithelial response circuit to enforce intestinal host defence. Nat. Commun. 13, 874 (2022).","journal-title":"Nat. Commun."},{"key":"73760_CR54","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.cell.2014.01.026","volume":"156","author":"M Wlodarska","year":"2014","unstructured":"Wlodarska, M. et al. NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion. Cell 156, 1045\u20131059 (2014).","journal-title":"Cell"},{"key":"73760_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114206","volume":"43","author":"A Singh","year":"2024","unstructured":"Singh, A. et al. IL-22 promotes mucin-type O-glycosylation and MATH1(+) cell-mediated amelioration of intestinal inflammation. Cell Rep. 43, 114206 (2024).","journal-title":"Cell Rep."},{"key":"73760_CR56","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41586-019-1082-x","volume":"568","author":"L Zhou","year":"2019","unstructured":"Zhou, L. et al. Innate lymphoid cells support regulatory T cells in the intestine through interleukin-2. Nature 568, 405\u2013409 (2019).","journal-title":"Nature"},{"key":"73760_CR57","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1038\/s41596-020-00482-1","volume":"16","author":"PB J\u00f8rgensen","year":"2021","unstructured":"J\u00f8rgensen, P. B. et al. Identification, isolation and analysis of human gut-associated lymphoid tissues. Nat. Protoc. 16, 2051\u20132067 (2021).","journal-title":"Nat. Protoc."},{"key":"73760_CR58","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jim.2015.02.012","volume":"421","author":"R Bowcutt","year":"2015","unstructured":"Bowcutt, R. et al. Isolation and cytokine analysis of lamina propria lymphocytes from mucosal biopsies of the human colon. J. Immunol. Methods 421, 27\u201335 (2015).","journal-title":"J. Immunol. Methods"},{"key":"73760_CR59","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41577-019-0125-8","volume":"19","author":"V Rothhammer","year":"2019","unstructured":"Rothhammer, V. & Quintana, F. J. The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease. Nat. Rev. Immunol. 19, 184\u2013197 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"73760_CR60","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev.pharmtox.43.100901.135828","volume":"43","author":"MS Denison","year":"2003","unstructured":"Denison, M. S. & Nagy, S. R. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev. Pharm. Toxicol. 43, 309\u2013334 (2003).","journal-title":"Annu Rev. Pharm. Toxicol."},{"key":"73760_CR61","first-page":"47","volume":"103","author":"NI Kerkvliet","year":"1995","unstructured":"Kerkvliet, N. I. Immunological effects of chlorinated dibenzo-p-dioxins. Environ. Health Perspect. 103, 47\u201353 (1995).","journal-title":"Environ. Health Perspect."},{"key":"73760_CR62","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1615\/CritRevEukarGeneExpr.v18.i3.20","volume":"18","author":"TV Beischlag","year":"2008","unstructured":"Beischlag, T. V., Luis Morales, J., Hollingshead, B. D. & Perdew, G. H. The aryl hydrocarbon receptor complex and the control of gene expression. Crit. Rev. Eukaryot. Gene Expr. 18, 207\u2013250 (2008).","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"73760_CR63","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1124\/dmd.115.064246","volume":"43","author":"TD Hubbard","year":"2015","unstructured":"Hubbard, T. D., Murray, I. A. & Perdew, G. H. Indole and tryptophan metabolism: endogenous and dietary routes to Ah receptor activation. Drug Metab. Dispos. 43, 1522\u20131535 (2015).","journal-title":"Drug Metab. Dispos."},{"key":"73760_CR64","doi-asserted-by":"publisher","first-page":"1788899","DOI":"10.1080\/19490976.2020.1788899","volume":"12","author":"F Dong","year":"2020","unstructured":"Dong, F. et al. Intestinal microbiota-derived tryptophan metabolites are predictive of Ah receptor activity. Gut Microbes 12, 1788899 (2020).","journal-title":"Gut Microbes"},{"key":"73760_CR65","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cotox.2018.11.005","volume":"11-12","author":"Stephen Safe","year":"2018","unstructured":"Safe, S. tephen, Han, H. uajun, Goldsby, J. ennifer, Mohankumar, K. umaravel & Chapkin, R. S. Aryl hydrocarbon receptor (AhR) ligands as selective AhR modulators: Genomic studies. Curr. Opin. Toxicol. 11-12, 10\u201320 (2018).","journal-title":"Curr. Opin. Toxicol."},{"key":"73760_CR66","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1021\/tx100045h","volume":"23","author":"IA Murray","year":"2010","unstructured":"Murray, I. A. et al. Development of a selective modulator of aryl hydrocarbon (Ah) receptor activity that exhibits anti-inflammatory properties. Chem. Res. Toxicol. 23, 955\u2013966 (2010).","journal-title":"Chem. Res. Toxicol."},{"key":"73760_CR67","doi-asserted-by":"publisher","first-page":"6654","DOI":"10.3390\/ijms21186654","volume":"21","author":"S Safe","year":"2020","unstructured":"Safe, S., Jin, U. H., Park, H., Chapkin, R. S. & Jayaraman, A. Aryl Hydrocarbon Receptor (AHR) ligands as selective AHR modulators (SAhRMs). Int. J. Mol. Sci. 21, 6654 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"73760_CR68","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13578-023-01046-y","volume":"13","author":"Y Chen","year":"2023","unstructured":"Chen, Y., Wang, Y., Fu, Y., Yin, Y. & Xu, K. Modulating AHR function offers exciting therapeutic potential in gut immunity and inflammation. Cell Biosci. 13, 85 (2023).","journal-title":"Cell Biosci."},{"key":"73760_CR69","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/s41385-018-0019-2","volume":"11","author":"B Lamas","year":"2018","unstructured":"Lamas, B., Natividad, J. M. & Sokol, H. Aryl hydrocarbon receptor and intestinal immunity. Mucosal Immunol. 11, 1024\u20131038 (2018).","journal-title":"Mucosal Immunol."},{"key":"73760_CR70","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s41575-021-00430-8","volume":"18","author":"B Stockinger","year":"2021","unstructured":"Stockinger, B., Shah, K. & Wincent, E. AHR in the intestinal microenvironment: safeguarding barrier function. Nat. Rev. Gastroenterol. Hepatol. 18, 559\u2013570 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"73760_CR71","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1002\/eji.201040461","volume":"40","author":"JM Ramirez","year":"2010","unstructured":"Ramirez, J. M. et al. Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cells. Eur. J. Immunol. 40, 2450\u20132459 (2010).","journal-title":"Eur. J. Immunol."},{"key":"73760_CR72","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.3389\/fimmu.2020.02148","volume":"11","author":"T Arshad","year":"2020","unstructured":"Arshad, T., Mansur, F., Palek, R., Manzoor, S. & Liska, V. A Double-edged sword role of interleukin-22 in wound healing and tissue regeneration. Front. Immunol. 11, 2148 (2020).","journal-title":"Front. Immunol."},{"key":"73760_CR73","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.3389\/fimmu.2020.01315","volume":"11","author":"H-X Wei","year":"2020","unstructured":"Wei, H. -X, Wang, B. & Li, B. IL-10 and IL-22 in mucosal immunity: driving protection and path. Front Immunol. 11, 1315 (2020).","journal-title":"Front Immunol."},{"key":"73760_CR74","doi-asserted-by":"publisher","first-page":"6829","DOI":"10.4049\/jimmunol.162.11.6829","volume":"162","author":"TT Pizarro","year":"1999","unstructured":"Pizarro, T. T. et al. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn\u2019s disease: expression and localization in intestinal mucosal cells.  J. Immunol. 162, 6829\u20136835 (1999).","journal-title":"J. Immunol."},{"key":"73760_CR75","first-page":"2291","volume":"43","author":"Z Pu","year":"2019","unstructured":"Pu, Z. et al. Dual roles of IL-18 in colitis through regulation of the function and quantity of goblet cells. Int J. Mol. Med. 43, 2291\u20132302 (2019).","journal-title":"Int J. Mol. Med."},{"key":"73760_CR76","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/cei.12806","volume":"185","author":"GX Yang","year":"2016","unstructured":"Yang, G. X. et al. Endogenous interleukin-22 protects against inflammatory bowel disease but not autoimmune cholangitis in dominant negative form of transforming growth factor beta receptor type II mice. Clin. Exp. Immunol. 185, 154\u2013164 (2016).","journal-title":"Clin. Exp. Immunol."},{"key":"73760_CR77","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1136\/gutjnl-2019-318483","volume":"69","author":"N Powell","year":"2020","unstructured":"Powell, N. et al. Interleukin-22 orchestrates a pathological endoplasmic reticulum stress response transcriptional program in colonic epithelial cells. Gut 69, 578\u2013590 (2020).","journal-title":"Gut"},{"key":"73760_CR78","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1084\/jem.20100199","volume":"207","author":"R Salcedo","year":"2010","unstructured":"Salcedo, R. et al. MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18. J. Exp. Med. 207, 1625\u20131636 (2010).","journal-title":"J. Exp. Med."},{"key":"73760_CR79","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/imr.12616","volume":"281","author":"G Kaplanski","year":"2018","unstructured":"Kaplanski, G. Interleukin-18: Biological properties and role in disease pathogenesis. Immunol. Rev. 281, 138\u2013153 (2018).","journal-title":"Immunol. Rev."},{"key":"73760_CR80","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3389\/fimmu.2013.00289","volume":"4","author":"CA Dinarello","year":"2013","unstructured":"Dinarello, C. A., Novick, D., Kim, S. & Kaplanski, G. Interleukin-18 and IL-18 binding protein. Front. Immunol. 4, 289 (2013).","journal-title":"Front. Immunol."},{"key":"73760_CR81","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/intimm\/dxu066","volume":"26","author":"N Gagliani","year":"2014","unstructured":"Gagliani, N., Palm, N. W., de Zoete, M. R. & Flavell, R. A. Inflammasomes and intestinal homeostasis: regulating and connecting infection, inflammation and the microbiota. Int. Immunol. 26, 495\u2013499 (2014).","journal-title":"Int. Immunol."},{"key":"73760_CR82","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/s41385-020-0256-z","volume":"13","author":"L Ghimire","year":"2020","unstructured":"Ghimire, L., Paudel, S., Jin, L. & Jeyaseelan, S. The NLRP6 inflammasome in health and disease. Mucosal Immunol. 13, 388\u2013398 (2020).","journal-title":"Mucosal Immunol."},{"key":"73760_CR83","doi-asserted-by":"publisher","first-page":"e0175336","DOI":"10.1371\/journal.pone.0175336","volume":"12","author":"F Awad","year":"2017","unstructured":"Awad, F. et al. Impact of human monocyte and macrophage polarization on NLR expression and NLRP3 inflammasome activation. PLoS ONE 12, e0175336 (2017).","journal-title":"PLoS ONE"},{"key":"73760_CR84","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.it.2015.06.002","volume":"36","author":"ME Sellin","year":"2015","unstructured":"Sellin, M. E., Maslowski, K. M., Maloy, K. J. & Hardt, W. D. Inflammasomes of the intestinal epithelium. Trends Immunol. 36, 442\u2013450 (2015).","journal-title":"Trends Immunol."},{"key":"73760_CR85","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41590-020-0681-x","volume":"21","author":"S Mukherjee","year":"2020","unstructured":"Mukherjee, S. et al. Deubiquitination of NLRP6 inflammasome by Cyld critically regulates intestinal inflammation. Nat. Immunol. 21, 626\u2013635 (2020).","journal-title":"Nat. Immunol."},{"key":"73760_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-45747-2","volume":"9","author":"LE Mokry","year":"2019","unstructured":"Mokry, L. E. et al. Interleukin-18 as a drug repositioning opportunity for inflammatory bowel disease: a Mendelian randomization study. Sci. Rep. 9, 9386 (2019).","journal-title":"Sci. Rep."},{"key":"73760_CR87","doi-asserted-by":"publisher","first-page":"8711","DOI":"10.3748\/wjg.v21.i28.8711","volume":"21","author":"SJ Gao","year":"2015","unstructured":"Gao, S. J. et al. Interleukin-18 genetic polymorphisms contribute differentially to the susceptibility to Crohn\u2019s disease. World J. Gastroenterol. 21, 8711\u20138722 (2015).","journal-title":"World J. Gastroenterol."},{"key":"73760_CR88","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1177\/0961203311400114","volume":"20","author":"HF Pan","year":"2011","unstructured":"Pan, H. F., Leng, R. X. & Ye, D. Q. Lack of association of interleukin-18 gene promoter -607 A\/C polymorphism with susceptibility to autoimmune diseases: a meta-analysis. Lupus 20, 945\u2013951 (2011).","journal-title":"Lupus"},{"key":"73760_CR89","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/j.1365-2249.2004.02362.x","volume":"135","author":"P Maerten","year":"2004","unstructured":"Maerten, P. et al. Involvement of interleukin 18 in Crohn\u2019s disease: evidence from in vitro analysis of human gut inflammatory cells and from experimental colitis models. Clin. Exp. Immunol. 135, 310\u2013317 (2004).","journal-title":"Clin. Exp. Immunol."},{"key":"73760_CR90","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1002\/eji.200425351","volume":"34","author":"BK Reuter","year":"2004","unstructured":"Reuter, B. K. & Pizarro, T. T. Commentary: the role of the IL-18 system and other members of the IL-1R\/TLR superfamily in innate mucosal immunity and the pathogenesis of inflammatory bowel disease: friend or foe? Eur. J. Immunol. 34, 2347\u20132355 (2004).","journal-title":"Eur. J. Immunol."},{"key":"73760_CR91","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.cell.2015.10.072","volume":"163","author":"R Nowarski","year":"2015","unstructured":"Nowarski, R. et al. Epithelial IL-18 equilibrium controls barrier function in colitis. Cell 163, 1444\u20131456 (2015).","journal-title":"Cell"},{"key":"73760_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2022.108963","volume":"207","author":"J Qiu","year":"2022","unstructured":"Qiu, J. et al. Urolithin A promotes mitophagy and suppresses NLRP3 inflammasome activation in lipopolysaccharide-induced BV2 microglial cells and MPTP-induced Parkinson\u2019s disease model. Neuropharmacology 207, 108963 (2022).","journal-title":"Neuropharmacology"},{"key":"73760_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114057","volume":"148","author":"K Chen","year":"2025","unstructured":"Chen, K. et al. Urolithin A alleviates NLRP3 inflammasome activation and pyroptosis by promoting microglial mitophagy following spinal cord injury. Int Immunopharmacol. 148, 114057 (2025).","journal-title":"Int Immunopharmacol."},{"key":"73760_CR94","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4161\/gmic.1.1.10470","volume":"1","author":"GC Hansson","year":"2010","unstructured":"Hansson, G. C. & Johansson, M. E. The inner of the two Muc2 mucin-dependent mucus layers in the colon is devoid of bacteria. Gut Microbes 1, 51\u201354 (2010).","journal-title":"Gut Microbes"},{"key":"73760_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103751","volume":"74","author":"D Yao","year":"2021","unstructured":"Yao, D., Dai, W., Dong, M., Dai, C. & Wu, S. MUC2 and related bacterial factors: Therapeutic targets for ulcerative colitis. EBioMedicine 74, 103751 (2021).","journal-title":"EBioMedicine"},{"key":"73760_CR96","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.3389\/fimmu.2020.02054","volume":"11","author":"JA Grondin","year":"2020","unstructured":"Grondin, J. A., Kwon, Y. H., Far, P. M., Haq, S. & Khan, W. I. Mucins in intestinal mucosal defense and inflammation: learning from clinical and experimental studies. Front Immunol. 11, 2054 (2020).","journal-title":"Front Immunol."},{"key":"73760_CR97","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1053\/j.gastro.2006.04.020","volume":"131","author":"M Van der Sluis","year":"2006","unstructured":"Van der Sluis, M. et al. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 131, 117\u2013129 (2006).","journal-title":"Gastroenterology"},{"key":"73760_CR98","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1084\/jem.20061308","volume":"203","author":"SC Liang","year":"2006","unstructured":"Liang, S. C. et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance the expression of antimicrobial peptides. J. Exp. Med. 203, 2271\u20132279 (2006).","journal-title":"J. Exp. Med."},{"key":"73760_CR99","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1146\/annurev-immunol-032414-112123","volume":"33","author":"JA Dudakov","year":"2015","unstructured":"Dudakov, J. A., Hanash, A. M. & van den Brink, M. R. Interleukin-22: immunobiology and pathology. Annu Rev. Immunol. 33, 747\u2013785 (2015).","journal-title":"Annu Rev. Immunol."},{"key":"73760_CR100","first-page":"534","volume":"118","author":"K Sugimoto","year":"2008","unstructured":"Sugimoto, K. et al. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J. Clin. Invest. 118, 534\u2013544 (2008).","journal-title":"J. Clin. Invest."},{"key":"73760_CR101","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.immuni.2015.01.011","volume":"42","author":"M Munoz","year":"2015","unstructured":"Munoz, M. et al. Interleukin-22 induces interleukin-18 expression from epithelial cells during intestinal infection. Immunity 42, 321\u2013331 (2015).","journal-title":"Immunity"},{"key":"73760_CR102","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.4049\/jimmunol.1601554","volume":"199","author":"AR Victor","year":"2017","unstructured":"Victor, A. R. et al. IL-18 drives ILC3 proliferation and promotes IL-22 Production via NF-\u03baB. J. Immunol. 199, 2333\u20132342 (2017).","journal-title":"J. Immunol."},{"key":"73760_CR103","doi-asserted-by":"publisher","first-page":"18177","DOI":"10.3748\/wjg.v20.i48.18177","volume":"20","author":"LJ Li","year":"2014","unstructured":"Li, L. J., Gong, C., Zhao, M. H. & Feng, B. S. Role of interleukin-22 in inflammatory bowel disease. World J. Gastroenterol. 20, 18177\u201318188 (2014).","journal-title":"World J. Gastroenterol."},{"key":"73760_CR104","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00535-017-1401-7","volume":"53","author":"A Mizoguchi","year":"2018","unstructured":"Mizoguchi, A. et al. Clinical importance of IL-22 cascade in IBD. J. Gastroenterol. 53, 465\u2013474 (2018).","journal-title":"J. Gastroenterol."},{"key":"73760_CR105","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1002\/ibd.22929","volume":"18","author":"A Mizoguchi","year":"2012","unstructured":"Mizoguchi, A. Healing of intestinal inflammation by IL-22. Inflamm. Bowel Dis. 18, 1777\u20131784 (2012).","journal-title":"Inflamm. Bowel Dis."},{"key":"73760_CR106","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/nm.4106","volume":"22","author":"V Rothhammer","year":"2016","unstructured":"Rothhammer, V. et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat. Med. 22, 586\u2013597 (2016).","journal-title":"Nat. Med."},{"key":"73760_CR107","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00281-013-0393-5","volume":"35","author":"J Qiu","year":"2013","unstructured":"Qiu, J. & Zhou, L. Aryl hydrocarbon receptor promotes ROR\u03b3t\u207a group 3 ILCs and controls intestinal immunity and inflammation. Semin. Immunopathol. 35, 657\u2013670 (2013).","journal-title":"Semin. Immunopathol."},{"key":"73760_CR108","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.cell.2019.12.002","volume":"180","author":"F Matheis","year":"2020","unstructured":"Matheis, F. et al. Adrenergic signaling in muscularis macrophages limits infection-induced neuronal loss. Cell 180, 64\u201378.e16 (2020).","journal-title":"Cell"},{"key":"73760_CR109","doi-asserted-by":"publisher","first-page":"e00550","DOI":"10.1128\/IAI.00550-19","volume":"87","author":"G Trevejo-Nunez","year":"2019","unstructured":"Trevejo-Nunez, G. et al. Interleukin-22 (IL-22) binding protein constrains IL-22 activity, host defense, and oxidative phosphorylation genes during pneumococcal pneumonia. Infect. Immun. 87, e00550\u2013e00619 (2019).","journal-title":"Infect. Immun."},{"key":"73760_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100320","volume":"2","author":"B Mihi","year":"2021","unstructured":"Mihi, B. et al. Interleukin-22 signaling attenuates necrotizing enterocolitis by promoting epithelial cell regeneration. Cell Rep. Med. 2, 100320 (2021).","journal-title":"Cell Rep. Med."},{"key":"73760_CR111","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1128\/IAI.01268-15","volume":"84","author":"M Zheng","year":"2016","unstructured":"Zheng, M. et al. Therapeutic role of interleukin 22 in experimental intra-abdominal Klebsiella pneumoniae infection in mice. Infect. Immun. 84, 782\u2013789 (2016).","journal-title":"Infect. Immun."},{"key":"73760_CR112","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45568-6","volume":"15","author":"SJ Gaudino","year":"2024","unstructured":"Gaudino, S. J. et al. Intestinal IL-22RA1 signaling regulates intrinsic and systemic lipid and glucose metabolism to alleviate obesity-associated disorders. Nat. Commun. 15, 1597 (2024).","journal-title":"Nat. Commun."},{"key":"73760_CR113","first-page":"4557","volume":"7","author":"U Erben","year":"2014","unstructured":"Erben, U. et al. A guide to histomorphological evaluation of intestinal inflammation in mouse models. Int J. Clin. Exp. Pathol. 7, 4557\u20134576 (2014).","journal-title":"Int J. Clin. Exp. Pathol."},{"key":"73760_CR114","first-page":"e32033","volume":"14","author":"K Vadivazhagan","year":"2022","unstructured":"Vadivazhagan, K., Amitkumar, K. & Sudalaimuthu, M. Quantitative analysis of mucin expression using combined alcian blue-periodic acid schiff (AB-PAS) stain and combined high iron diamine-alcian blue (HID-AB) stain and the correlation with histomorphological score in chronic calculous cholecystitis. Cureus 14, e32033 (2022).","journal-title":"Cureus"},{"key":"73760_CR115","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1002\/ijc.33477","volume":"148","author":"VR Jala","year":"2021","unstructured":"Jala, V. R. et al. Absence of CCR2 reduces spontaneous intestinal tumorigenesis in the Apc(Min) (\/+) mouse model. Int. J. Cancer 148, 2594\u20132607 (2021).","journal-title":"Int. J. Cancer"},{"key":"73760_CR116","doi-asserted-by":"publisher","first-page":"5574","DOI":"10.7150\/thno.70754","volume":"12","author":"S Ghosh","year":"2022","unstructured":"Ghosh, S. et al. Microbial metabolite restricts 5-fluorouracil-resistant colonic tumor progression by sensitizing drug transporters via regulation of FOXO3-FOXM1 axis. Theranostics 12, 5574\u20135595 (2022).","journal-title":"Theranostics"},{"key":"73760_CR117","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s00204-022-03232-2","volume":"96","author":"S Ghosh","year":"2022","unstructured":"Ghosh, S., Banerjee, M., Haribabu, B. & Jala, V. R. Urolithin A attenuates arsenic-induced gut barrier dysfunction. Arch. Toxicol. 96, 987\u20131007 (2022).","journal-title":"Arch. Toxicol."},{"key":"73760_CR118","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.563414","volume":"11","author":"A Valle-Noguera","year":"2020","unstructured":"Valle-Noguera, A., Gomez-Sanchez, M. J., Girard-Madoux, M. J. H. & Cruz-Adalia, A. Optimized protocol for characterization of mouse gut innate lymphoid cells. Front Immunol. 11, 563414 (2020).","journal-title":"Front Immunol."},{"key":"73760_CR119","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/s41586-024-07537-3","volume":"630","author":"A Ahmed","year":"2024","unstructured":"Ahmed, A. et al. CTLA-4-expressing ILC3s restrain interleukin-23-mediated inflammation. Nature 630, 976\u2013983 (2024).","journal-title":"Nature"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73760-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73760-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73760-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T09:22:00Z","timestamp":1782206520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73760-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":119,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["73760"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-73760-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"VRJ is one of the co-founders of Artus Therapeutics. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5411"}}